2014
DOI: 10.1016/j.antiviral.2014.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Pathophysiology of a severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
28
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 34 publications
(30 citation statements)
references
References 16 publications
1
28
0
Order By: Relevance
“…In contrast, PUUV disease exhibits a low CFR of less than 1% [31]. However, diseases caused by DOBV-Sochi and PUUV infection may also differ individually and cases of severe hantavirus disease due to PUUV infection were reported [14, 32, 33]. We compared two severe hantavirus infections caused by these two different virus species, PUUV and DOBV-Sochi.…”
Section: Discussionmentioning
confidence: 99%
“…In contrast, PUUV disease exhibits a low CFR of less than 1% [31]. However, diseases caused by DOBV-Sochi and PUUV infection may also differ individually and cases of severe hantavirus disease due to PUUV infection were reported [14, 32, 33]. We compared two severe hantavirus infections caused by these two different virus species, PUUV and DOBV-Sochi.…”
Section: Discussionmentioning
confidence: 99%
“…• Vascular leakage is described for virtually all forms of Hantavirus infection, and while the mechanism remains unknown, it is believed to involve inflammatory immune responses. • Presently, treatment options for NE as well as other Hantavirus-associated pathologies are limited [46,47]. For these reasons, future studies into the inflammatory mechanism of hantavirus infection will lead to greater understanding of disease pathogenesis and, in turn, may lead to improved treatment strategies and options for healthcare practitioners.…”
Section: Conclusion and Future Perspectivementioning
confidence: 97%
“…Recently it is reported that icadibant may be effective in infections caused by PUUV and many other hantavirus subtypes by preventing the binding of bradykinin [25] . Favipiravir (T-705, 6-fluoro-3-hydroxy-2-pyrazinecarboxamide) has been shown to be highly active against many Bunyaviruses via inhibiting viral replication and cytopathic effect [26,27] .…”
Section: Treatment Antiviral Drugsmentioning
confidence: 99%